(0.25%) 5 321.41 points
(0.17%) 39 873 points
(0.22%) 16 833 points
(-0.93%) $79.06
(-0.45%) $2.66
(-0.03%) $2 425.20
(0.40%) $32.21
(0.18%) $1 062.80
(0.04%) $0.921
(-0.06%) $10.69
(-0.04%) $0.787
(-0.49%) $90.23
-0.54% $ 0.370
Live Chart Being Loaded With Signals
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics...
Stats | |
---|---|
Dzisiejszy wolumen | 205 779 |
Średni wolumen | 891 846 |
Kapitalizacja rynkowa | 47.52M |
EPS | $0 ( 2024-05-10 ) |
Następna data zysków | ( $-0.0800 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.790 |
ATR14 | $0.00400 (1.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-30 | General Resonance Llc | Sell | 13 000 | Common Stock |
2024-05-01 | General Resonance Llc | Sell | 13 000 | Common Stock |
2024-04-24 | General Resonance Llc | Sell | 10 000 | Common Stock |
2024-04-09 | General Resonance Llc | Sell | 7 500 | Common Stock |
2024-04-09 | General Resonance Llc | Sell | 7 500 | Common Stock |
INSIDER POWER |
---|
98.96 |
Last 99 transactions |
Buy: 46 123 962 | Sell: 192 230 |
Wolumen Korelacja
Clene Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Clene Inc. Korelacja - Waluta/Towar
Clene Inc. Finanse
Annual | 2023 |
Przychody: | $654 000 |
Zysk brutto: | $-1.17M (-179.20 %) |
EPS: | $-0.470 |
FY | 2023 |
Przychody: | $654 000 |
Zysk brutto: | $-1.17M (-179.20 %) |
EPS: | $-0.470 |
FY | 2022 |
Przychody: | $473 000 |
Zysk brutto: | $447 000 (94.50 %) |
EPS: | $-0.230 |
FY | 2021 |
Przychody: | $723 000 |
Zysk brutto: | $434 000 (60.03 %) |
EPS: | $-0.160 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Clene Inc.
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; ongoing Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a planned Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej